Publication:
Drug-Resistant Infections: A Threat to Our Economic Future

Simple item page
dc.contributor.authorWorld Bank
dc.date.accessioned2017-05-22T21:13:16Z
dc.date.available2017-05-22T21:13:16Z
dc.date.issued2017-03
dc.description.abstractThis report examines the economic and development consequences of antimicrobial resistance(AMR)—the capacity that disease-causing microorganisms acquire to resist the drugs we've createdto fight them. The report uses World Bank Group economic simulation tools to put a price tag onAMR's destructive impacts on the global economy from 2017 through 2050, if adequate measuresaren't taken to contain the AMR threat. The report highlights actions low- and middle-income countries and their development partners can take to counter AMR, and estimates the investment required. It shows that putting resources into AMR containment now is one of the highest-yield investments countries can make. Antimicrobials are drugs that destroy disease-causing microbes, also called pathogens, such as certain bacteria, viruses, parasites, and fungi. The most familiar and important antimicrobials are antibiotics, which treat bacterial infections. Other antimicrobials combat viral and parasitic diseases, such as AIDS and malaria. Since their use began some 70 years ago, antimicrobials have saved hundreds of millions of lives.en
dc.identifierhttp://documents.worldbank.org/curated/en/323311493396993758/final-report
dc.identifier.doi10.1596/26707
dc.identifier.urihttps://hdl.handle.net/10986/26707
dc.languageEnglish
dc.language.isoen_US
dc.publisherWorld Bank, Washington, DC
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectANTIMICROBIALS
dc.subjectDRUG-RESISTANT INFECTIONS
dc.subjectANTIMICROBIAL RESISTANCE
dc.subjectECONOMIC IMPACT
dc.subjectHEALTHCARE
dc.subjectINTERNATIONAL COOPERATION
dc.subjectSDGs
dc.subjectANIMAL HEALTH
dc.subjectDISEASE CONTROL
dc.subjectEPIDEMICS
dc.titleDrug-Resistant Infectionsen
dc.title.subtitleA Threat to Our Economic Futureen
dc.typeReporten
dc.typeRapportfr
dc.typeInformees
dspace.entity.typePublication
okr.crossref.titleDrug-Resistant Infections
okr.date.disclosure2017-04-28
okr.doctypePublications & Research
okr.doctypePublications & Research::Working Paper
okr.docurlhttp://documents.worldbank.org/curated/en/323311493396993758/final-report
okr.guid455311493396671601
okr.guid323311493396993758
okr.identifier.doi10.1596/26707
okr.identifier.externaldocumentum090224b084b5ebce_2_0
okr.identifier.internaldocumentum27408879
okr.identifier.report114679
okr.importedtrue
okr.language.supporteden
okr.pdfurlhttp://documents.worldbank.org/curated/en/323311493396993758/pdf/114679-REVISED-v2-Drug-Resistant-Infections-Final-Report.pdfen
okr.topicHealth, Nutrition and Population::Disease Control & Prevention
okr.topicHealth, Nutrition and Population::Health Economics & Finance
okr.topicHealth, Nutrition and Population::Health Monitoring & Evaluation
okr.topicHealth, Nutrition and Population::Health Policy and Management
okr.unitHDN Practice Group (ECRHD)
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
114679-REVISED-v2-Drug-Resistant-Infections-Final-Report.pdf
Size:
3.75 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
114679-REVISED-v2-Drug-Resistant-Infections-Final-Report.txt
Size:
746.49 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Other papers